课题基金 / 基金详情

A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR

A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR
Quadr 安全性和免疫原性的单臂、开放标签试点试验
批准号：
8167122
负责人：
RONALD T. MITSUYASU
金额：
$9.41万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-12-01 至 2010-11-30
来源：
https://reporter.nih.gov/project-details/8167122
关键词：
AntibodiesComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantHuman Papilloma Virus VaccineHuman PapillomavirusInstitutionRecombinant VaccinesResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Healtharmimmunogenicitymenopen labelpilot trial

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To assess the safety and tolerability of the quadrivalent HPV recombinant vaccine in HIV-infected men. To assess the immunogenicity of the quadrivalent HPV vaccine for types 6, 11, 16 and 18 in subjects who are antibody-negative at baseline.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)